Nephrology & Urology Clinical Trials

Statistical methods in nephrology & urology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All nephrology & urology trials

489 results

• Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: Complete Statistical AnalysisIndependent statistical analysis of Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02352103).Phase 3Results postedn = 120NCT02352103
• Improving Care for Women With Urinary Incontinence (EMPOWER): Complete Statistical AnalysisIndependent statistical analysis of Improving Care for Women With Urinary Incontinence (EMPOWER): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05515198).Phase NAResults postedn = 400NCT05515198
• Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD: Complete Statistical AnalysisIndependent statistical analysis of Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05734989).Phase NAResults postedn = 248NCT05734989
• Improving Urinary Continence and Quality of Life in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Improving Urinary Continence and Quality of Life in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 279NCT01365182
• Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 30NCT03010137
• Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning: Complete Statistical AnalysisIndependent statistical analysis of Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02470910).Phase NAResults postedn = 15NCT02470910
• Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: primary endpoint results, effect estimate with confidence interval,…Phase NAResults postedn = 550NCT03860961
• Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury: Complete Statistical AnalysisIndependent statistical analysis of Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02165072).Phase NAResults postedn = 30NCT02165072
• Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics: Complete Statistical AnalysisIndependent statistical analysis of Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04090190).Phase 4Results postedn = 20NCT04090190
• Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 172NCT00818623
• Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.: Complete Statistical AnalysisIndependent statistical analysis of Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01574157).Phase NAResults postedn = 74NCT01574157
• IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?: Complete Statistical AnalysisIndependent statistical analysis of IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 4Results postedn = 40NCT02625428
• Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 1,538NCT02940860
• JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD): Complete Statistical AnalysisIndependent statistical analysis of JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 299NCT06287073
• KAMELEONIndependent statistical analysis of A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors: primary endpoint results, effect estimate with confidence…Phase 2Results postedn = 20NCT02999672
• KHLADIndependent statistical analysis of Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00953576).Phase 1/2Results postedn = 11NCT00953576
• KIDPROAMIndependent statistical analysis of Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 144NCT01245595
• Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval,…Phase 1/2Results postedn = 10NCT01163084
• Lighting Intervention for Cancer-related Fatigue: Complete Statistical AnalysisIndependent statistical analysis of Lighting Intervention for Cancer-related Fatigue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04827446).Phase NAResults postedn = 139NCT04827446
• Low Dose Thymoglobin in Renal Transplant Patients: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Thymoglobin in Renal Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01280617).Phase NAResults postedn = 44NCT01280617
• M-RePoRTIndependent statistical analysis of Metformin for Rising PSA Remote Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02376166).Phase NAResults postedn = 15NCT02376166
• MAGE-A4ᶜ¹º³²T for Multi-Tumor: Complete Statistical AnalysisIndependent statistical analysis of MAGE-A4ᶜ¹º³²T for Multi-Tumor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03132922).Phase 1Results postedn = 71NCT03132922
• MAPSIndependent statistical analysis of MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01411345).Phase NAResults postedn = 37NCT01411345
• MasterKey-01Independent statistical analysis of A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 1Results postedn = 91NCT04209465
• MAXIMIZAIndependent statistical analysis of Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza…Phase 4Results postedn = 89NCT01056822
• MDX1106-01Independent statistical analysis of A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 1Results postedn = 39NCT00441337
• Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01671605).Phase NAResults postedn = 103NCT01671605
• Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection: Complete Statistical AnalysisIndependent statistical analysis of Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00751140).Phase NAResults postedn = 20NCT00751140
• MERLINIndependent statistical analysis of A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 81NCT04702997
• Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01433913).Phase 2Results postedn = 20NCT01433913
• Metformin in Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Metformin in Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02252081).Phase 2Results postedn = 125NCT02252081
• Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs: Complete Statistical AnalysisIndependent statistical analysis of Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03077711).Phase 4Results postedn = 92NCT03077711
• METRASIndependent statistical analysis of Metabolites of Tramadol in the Postoperative Surgical Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04004481).Phase NAResults postedn = 50NCT04004481
• Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02457182).Phase NAResults postedn = 20NCT02457182
• Molecular-Guided Therapy for Childhood Cancer: Complete Statistical AnalysisIndependent statistical analysis of Molecular-Guided Therapy for Childhood Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02162732).Phase NAResults postedn = 186NCT02162732
• MORNDIABIndependent statistical analysis of Morbidity in Newly Diagnosed type2 Diabetes in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002091).Phase NAResults postedn = 327NCT02002091
• MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 27NCT01792024
• MRI Guided SBRT for Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of MRI Guided SBRT for Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03778112).Phase NAResults postedn = 54NCT03778112
• Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…Phase NAResults postedn = 1,676NCT02079025
• Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant: Complete Statistical AnalysisIndependent statistical analysis of Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 36NCT01666951
• Multicultural Healthy Diet in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Multicultural Healthy Diet in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05504850).Phase NAResults postedn = 18NCT05504850
• Nasal Tea Tree Oil for the Prevention of Infections in PD Patients: Complete Statistical AnalysisIndependent statistical analysis of Nasal Tea Tree Oil for the Prevention of Infections in PD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 5NCT01214395
• Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer: Complete Statistical AnalysisIndependent statistical analysis of Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 8NCT00328861
• NefigardIndependent statistical analysis of Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 365NCT03643965
• Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 118NCT02903368
• Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 2NCT01531205
• Neoadjuvant Immunotherapy in Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Immunotherapy in Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04434560).Phase 2Results postedn = 1NCT04434560
• Neoadjuvant Pazopanib in Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Pazopanib in Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01361113).Phase 2Results postedn = 21NCT01361113
• Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00828308).Phase 2Results postedn = 16NCT00828308
• NIAGARAIndependent statistical analysis of Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 1,063NCT03732677

← All therapeutic areas